Enabling people to control a computer with their mind and the completely blind to see are Jesus-level miracles.
💡 Inside Track & Deep Insight
Musk's hyperbolic language ('Jesus-level miracles') is typical but underscores a genuine breakthrough: Neuralink's N1 chip, with 1,024 electrodes on ultra-thin threads, has shown ability to decode neural signals for cursor control and, crucially, to stimulate the visual cortex to create artificial vision. The 'blindsight' project, aiming to restore sight even in those whose optic nerves are severed, relies on bypassing damaged eyes to feed visual data directly into the brain. This is a radical departure from retinal implants, which require functional retinal cells. For investors, Neuralink remains private and not publicly traded, but its progress affects sentiment for the broader neurotech sector (e.g., Synchron, Blackrock Neurotech) and could catalyze AI-brain interface stocks. In crypto, direct impact is minimal, but Musk's association with Dogecoin means any major breakthrough can fuel speculative rallies. The key risk: human trials are still limited; scalability and long-term safety are unproven. Still, if the 'blindsight' device achieves FDA breakthrough designation, expect a surge in neurotech ETFs and related biotech names.